Societal Implications of Medical Insurance Coverage for Imatinib as First-Line Treatment of Chronic Myeloid Leukaemia in China- A Cost Effectiveness Analysis
Abstract
Authors
S Chen C Dong G Sheng R Zhang M Miao D Wu T Xiong SC Tan C Liu